Physician profile
John Quinn
NPI 1578555819
$5,494.52
in general payments reported to CMS, 2019-2025
7 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $68.81 · 2021: $385 · 2022: $2,708 · 2023: $1,494 · 2024: $112 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,180 · Food and Beverage: $564 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $73.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,180.00 |
| Food and Beverage | $563.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $73.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $4,924.86 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $228.15 | 2023-2025 | |
| Allergan, INC. | $195.27 | 2019-2022 | |
| Galderma Laboratories, L.P. | $56.05 | 2019-2024 | |
| Revance Therapeutics, INC. | $36.05 | 2025 | Daxxify |
| Biosense Webster, INC. | $29.84 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Becton, Dickinson and Company | $24.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.